MedTrace Logo

Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Armenia

NCT01766388 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2014-07-09

No results posted yet for this study

Summary

The primary goal of this study is to examine the efficacy and feasibility of a mifepristone combined with misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Armenia.

Conditions

  • Abortion in Second Trimester

Sponsors & Collaborators

  • Gynuity Health Projects

    lead OTHER

Principal Investigators

  • Ruzanna Abrahamyan, MD · Republican Institute of Reproductive Health, Perinatology, Obstetrics and Gynecology

  • Gayane Abrahamyan, MD, PhD · State Medical University

  • Beverly Winikoff, MD, MPH · Gynuity Health Projects

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Armenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01766388 on ClinicalTrials.gov